H_HI_2022A 04/01/2022 11:54:14 AM Committee Summary

Representative Will and Representative Lindsay, co-prime sponsors, presented House Bill 22-1122 regarding pharmacy management regulation. The committee heard testimony on House Bill 22-1122 at its meeting on March 2, 2022. The sponsors discussed amendments L.001, L.002, L.004, and L.005 (Attachments A to D).

The committee recessed.

The committee came back to order.

Representative Lontine introduced House Bill 22-1246 regarding hospice inpatient unit specialized prescription drug outlets.

The committee took a brief recess.

The committee came back to order.

Representative Lontine introduced House Bill 22-1269 regarding healthcare sharing plan reporting requirements.

Mr. Joe Anderson, representing self, testified in opposition to the bill. Mr. Stuart Lark, representing the Christian Care Ministry, testified in opposition to the bill. Mr. Joel Noble, representing Samaritan Ministries, Int, testified in opposition to the bill. Mr. Ryan Bradbury, representing self, testified in opposition to the bill. Members of the panel answered questions from the committee.

Sara Froelich, representing the Chronic Care Collaborative, testified in support of the bill.
Stacey Gilbert, representing Denver Tech Insurance on Behalf of Good Business Colorado and The Colorado Health Initiative, testified in support of the bill.

Members of the panel answered questions from the committee.

Mr. Stephen Strawbridge, representing self, testified in opposition to the bill. Mrs. Katy Talento, representing the Alliance of Health Care Sharing Ministries, testified in opposition to the bill. Mr. Theodore Monsour, representing self, testified in opposition to the bill. Annette Budd, representing self, testified in opposition to the bill. Members of the panel answered questions from the committee.

Melissa O'Reilly, representing Sedera, testified in opposition to the bill.
Mr. David Fritzler, representing self, testified in opposition to the bill.
Mr. David Skarka, representing self, testified in opposition to the bill.
Ian Rutherford, representing self, testified in opposition to the bill.

Members of the panel answered questions from the committee.

Mr. Shane Duckworth, representing self, testified in opposition to the bill.
Lisa Hecker, representing self, testified in opposition to the bill.
Mr. Matthew Bellis, representing Liberty HealthShare, testified to amend the bill.
Kevin McBride, representing Impact Health, testified in opposition to the bill.

Ms. Bethany Pray, representing the Colorado Center on Law and Policy, testified in support of the bill. Ms. Isabel Cruz, representing the Colorado Consumer Health Initiative, testified in support of the bill. Peter Severson, representing the Lutheran Advocacy Ministry Colorado, testified in support of the bill. Salena Prinzmetal, representing the Colorado Consumer Health Initiative, testified in support of the bill. Members of the panel answered questions from the committee.

Dr. David Aronstein, representing self, testified in opposition to the bill.

Angelique Espinoza, representing Good Business Colorado, testified in support of the bill.
Theresa Brilli, representing self, testified in support of the bill.

Mr. Dana Bacon, representing the Leukemia and Lymphoma Society, testified in support of the bill.

Debra Judy, representing the Division of Insurance in the Department of Regulatory Agencies, testified in support of the bill. Mr. Keith Hopkinson, representing Christian Healthcare Ministries, testified in support of the bill. Jessalyn Hampton, representing Connect for Health Colorado, testified in support of the bill. The panelists responded to questions from the committee. Written testimony was provided to the committee (Attachment F).

Representative Baisley explained amendment L.005 (Attachment G). Committee discussion ensued.

Representative Baisley explained amendment L.006 (Attachment H). Committee discussion ensued.

Representative Baisley referenced amendments L.007 (Attachment I) and L.008 (Attachment J), but did not move those two amendments. He explained amendment L.009 (Attachment K). The committee recessed.

The committee came back to order.

Representative Baisley explained amendment L.010 (Attachment L). Committee discussion ensued.

Representative Baisley explained amendment L.011 (Attachment M). Committee discussion ensued.

Representative Baisley explained amendment L.012 (Attachment N). Committee discussion ensued.

Representative Baisley explained amendment L.013 (Attachment O). Committee discussion ensued.

Representative Baisley explained amendment L.014 (Attachment P). Committee discussion ensued.

Representative Baisley explained amendment L.015 (Attachment Q). Committee discussion ensued.

Representative Baisley explained amendment L.0016 (Attachment R). Committee discussion ensued.

Representative Lontine explained amendments L.001 (Attachment S) and L.018 (Attachment T).

Representative Lontine explained amendment L.020 (Attachment U).

Representative Lontine explained L.003 (Attachment V).

Representative Lontine explained amendment L.004 (Attachment W).

Representative Lontine explained amendment L.017 (Attachment X).

Representative Lontine explained amendment L.019 (Attachment Y).

Representative Lontine made concluding remarks about the bill. Committee members commented on the bill.

The committee recessed.

The committee came back to order.

Representative Baisley, prime bill sponsor, presented House Bill 22-1198, concerning requirements for organizations operating medical expense sharing programs in Colorado. The bill establishes requirements for medical expense sharing programs, provides the Attorney General with oversight and enforcement authority, and exempts medical expense sharing programs from insurance laws and rules. Representative Baisley provided a handout to the committee (Attachment Z). Representative Baisley responded to questions from the committee.

Keith Hopkinson, representing the Christian Healthcare Ministries, testified in opposition to the bill. Debra Judy, representing the Division of Insurance in the Department of Regulatory Agencies, testified in opposition to the bill. Ms. Bethany Pray, representing self, testified in opposition to the bill. Ms. Isabel Cruz, representing the Colorado Consumer Health Initiative, testified in opposition to the bill. Mr. Dana Bacon, representing the Leukemia and Lymphoma Society, testified in opposition to the bill. The panelists responded to questions from the committee.

Representative Baisley made concluding remarks about the bill. Committee members commented on the bill.